Nelson Cabatuan - 15 Feb 2023 Form 4 Insider Report for Rain Oncology Inc.

Role
VP of Finance & Admin
Signature
/s/ Avanish Vellanki, Attorney-in-fact for Nelson Cabatuan
Issuer symbol
N/A
Transactions as of
15 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 17:23:32 UTC
Previous filing
04 Feb 2022
Next filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +65,325 $0.000000 65,325 15 Feb 2023 Common Stock 65,325 $9.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 65,325 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.